Stock Screener App

Frei -

Installieren

1.10

4.76% 0.05

Century Therapeutics Inc (IPSC)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Century Therapeutics Inc-Aktie (IPSC)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	219.03% 0.855	0.268	0.148	0.099	1.72
Operating Expenses	26.95% 32.16	44.03	35.77	35.18	33.80
Benefits Costs and Expenses	28.66% 28.92	40.53	32.28	32.44	31.78
Costs And Expenses	28.66% 28.92	40.53	32.28	32.44	31.78
Operating Income/Loss	28.46% -31.31	-43.76	-35.63	-35.08	-32.08
Nonoperating Income/Loss	7.07% 3.248	3.495	3.498	2.736	2.025
Income/Loss From Continuing Operations Before Tax	30.31% -28.06	-40.27	-32.13	-32.34	-30.06
Income Tax Expense/Benefit	100.12% 0.001	-0.869	0.592	0.95	1.208
Income/Loss From Continuing Operations After Tax	28.77% -28.06	-39.40	-32.72	-33.29	-31.26
Net Income/Loss	28.77% -28.06	-39.40	-32.72	-33.29	-31.26
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	27,342% 62.30	0.227	59.45	59.25	58.61
Basic Earnings Per Share	30.77% -0.45	-0.65	-0.55	-0.56	-0.53
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

SMMT

$17.87

2.88%

INCY

$68.84

2.65%

MRNA

$39.39

0.43%

UTHR

$359.58

0.16%

BGNE

$176.50

1.02%

BNTX

$113.08

1.56%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters